Clinical Trial Update: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) [Phase 2]

View source ↗

Summary

A Takeda-sponsored Phase 2 trial evaluating Elritercept for treating anemia in adults with very low, low, or intermediate-risk myelodysplastic syndromes is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndromes

Drugs mentioned

• Elritercept (Elritercept)

Snippet

Sponsor: Takeda | Conditions: Myelodysplastic Syndromes, Cytopenia | Phase 2 | Status: RECRUITING